Anzeige
Mehr »
Login
Sonntag, 05.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Bevorstehende News könnten diesen Kupfer-Explorer ins große Rampenlicht katapultieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 03.01.2025

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
FrBriaCell Therapeutics Corp.: BriaCell Announces Proposed Effective Date of Share Consolidation43PHILADELPHIA and VANCOUVER, British Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology...
► Artikel lesen
FrPalisade Bio, Inc.: Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)40Carlsbad, CA, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) ("Palisade", "Palisade Bio", or the "Company"), a clinical-stage biopharmaceutical company focused on developing...
► Artikel lesen
FrAssertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)12LAKE FOREST, Ill., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering...
► Artikel lesen
FrORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)11SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address...
► Artikel lesen
FrOlema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)11SAN FRANCISCO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. ("Olema" or "Olema Oncology", Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development...
► Artikel lesen
FrCreative Realities Announces Departure of Will Logan, Chief Financial Officer47LOUISVILLE, Ky., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (NASDAQ: CREX) ("CRI" or the "Company"), a leading provider of digital signage and media solutions, today announced that...
► Artikel lesen
FrTeraWulf Inc.: TeraWulf Announces December 2024 Production and Operations Update34Secured high-performance computing (HPC) data center leases with Core42 for more than 70 MW of digital infrastructure, representing total revenue of more than $1 billion over initial 10-year term...
► Artikel lesen
FrProcaps Group, S.A.: Procaps Group Receives Additional Delinquency Letter92MIAMI and BARRANQUILLA, Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services...
► Artikel lesen
FrTandy Leather Factory, Inc.: Tandy Leather Factory Appoints new CEO; Announces Board Changes66FORT WORTH, Texas, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Tandy Leather Factory, Inc. (the "Company", Nasdaq: TLF) today announced it has appointed Johan Hedberg as its new Chief Executive Officer and...
► Artikel lesen
FrINLIF LIMITED Announces Closing of US$8 Million Initial Public Offering24Quanzhou, China, Jan. 03, 2025 (GLOBE NEWSWIRE) -- INLIF LIMITED (Nasdaq: INLF) (the "Company" or "INLIF"), a company engaged in the research, development, manufacturing, and sales of injection molding...
► Artikel lesen
FrVerve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)11BOSTON, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on December 31,...
► Artikel lesen
FrFate Therapeutics, Inc.: Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)19SAN DIEGO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent...
► Artikel lesen
FrCytokinetics, Incorporated: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)11SOUTH SAN FRANCISCO, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on December 31, 2024 it granted stock options to purchase an aggregate...
► Artikel lesen
FrSono Group N.V. Announces Reverse Share Split to Be Implemented January 6, 2025, the Signing of SPA for a new $5 million Debenture, and the Signing of an Exchange Agreement for the Exchange of All Its Debt to Equity25Munich, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The solar technology company Sono Group N.V. (OTCQB: SEVCF) (hereafter referred to as "Sono" or the "Company", parent company to Sono Motors GmbH or "Sono...
► Artikel lesen
FrTrust Stamp Previews Strategic Announcements34Atlanta, GA, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Gareth N. Genner, CEO of Trust Stamp, announced, "As our shareholders and observers know, our reverse split will be effective for trading on January...
► Artikel lesen
FrBoeing Appoints Deasy as Chief Information Officer34ARLINGTON, Va., Jan. 3, 2025 /PRNewswire/ -- Boeing [NYSE: BA] today announced Dana Deasy as the company's new chief information digital officer and senior vice...
► Artikel lesen
FrCNO Financial Group Names Joel Koehneman as Chief Accounting Officer30CARMEL, Ind., Jan. 3, 2025 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE: CNO) has named Joel Koehneman as Chief Accounting Officer, effective January 21, 2025. He will report to Chief...
► Artikel lesen
FrFCA US LLC: FCA US Reports Fourth-quarter and Full-year 2024 Sales Results53AUBURN HILLS, Mich., Jan. 3, 2025 /PRNewswire/ -- Company's U.S. Q4 2024 retail sales increased 1% versus same period last year Company's H2 2024 U.S. retail...
► Artikel lesen
FrSyndax Pharmaceuticals, Inc.: Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)12WALTHAM, Mass., Jan. 3, 2025 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline...
► Artikel lesen
FrInsmed Incorporated: Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)11BRIDGEWATER, N.J., Jan. 3, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first-...
► Artikel lesen
Seite:  Weiter >>